Butein blocks tumor necrosis factor α-induced interleukin 8 and matrix metalloproteinase 7 production by inhibiting p38 kinase and osteopontin mediated signaling events in HT-29 cells

Life Sciences

Volumn 81, Issue 21-22, 2007, Pages 1535-1543

  Lee, Sung Hee ^a   Seo, Geom Seog ^b   Jin, Xing Yu ^a   Ko, Geonil ^a   Sohn, Dong Hwan ^a  

^a Wonkwang University   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

Author keywords

Butein; I B phosphorylation; IL 8; Inflammatory bowel disease; MMP 7; Osteopontin; p38 MAPK; TNF

Indexed keywords

BUTEIN; I KAPPA B ALPHA; INTERLEUKIN 8; MATRILYSIN; OSTEOPONTIN; PHOSPHOTRANSFERASE INHIBITOR; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HT29; CELL VIABILITY; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CELL SURVIVAL; CHALCONES; ENZYME INHIBITORS; HT29 CELLS; HUMANS; I-KAPPA B KINASE; INDICATORS AND REAGENTS; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 7; OSTEOPONTIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35848968674     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.09.024     Document Type: Article

References (48)

1. Baeuerle P.A., and Baichwal V.R. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Advance in Immunology 65 (1997) 111-137
2. Bamba S., Lee C.Y., Brittan M., Preston S.L., Direkze N.C., Poulsom R., Alison M.R., Wright N.A., and Otto W.R. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. Journal of Pathology 209 (2006) 265-273
3. Bister V., Salmela M.T., Heikkila P., Anttila A., Rintala R., Isaka K., Andersson S., and Saarialho-Kere U. Matrilysins-1 and -2 (MMP-7 and -26) and metalloelastase (MMP-12), unlike MMP-19, are up-regulated in necrotizing enterocolitis. Journal of Pediatric Gastroenterology and Nutrition 40 (2005) 60-66
4. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nature Reviews. Molecular Cell Biology 3 (2002) 207-214
5. Castaneda F.E., Walia B., Vijay-Kumar M., Patel N.R., Roser S., Kolachala V.L., Rojas M., Wang L., Oprea G., Garg P., Gewirtz A.T., Roman J., Merlin D., and Sitaraman S.V. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 129 (2005) 1991-2008
6. Coëffier M., Marion R., Ducrotté P., and Déchelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clinical Nutrition 22 (2003) 407-413
7. Desbaillets I., Diserens A.C., de Tribolet N., Hamou M.F., and Van Meir E.G. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 18 (1999) 1447-1456
8. Di Sebastiano P., di Mola F.F., Artese L., Rossi C., Mascetta G., Pernthaler H., and Innocenti P. Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis. Digestion 63 (2001) 234-239
9. Finlay B.B., and Falkow S. Common themes in microbial pathogenicity revisited. Microbiology and Molecular Biology Reviews 61 (1997) 136-169
10. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
11. Gao Q., Meijer M.J., Kubben F.J., Sier C.F., Kruidenier L., van Duijn W., van den Berg M., van Hogezand R.A., Lamers C.B., and Verspaget H.W. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Digestive and Liver Disease 37 (2005) 584-592
12. Gerard C., and Rollins B.J. Chemokines and disease. Nature Immunology 2 (2001) 108-115
13. Gijsbers K., Van Assche G., Joossens S., Struyf S., Proost P., Rutgeerts P., Geboes K., and Van Damme J. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. European Journal of Immunology 34 (2004) 1992-2000
14. Hipp M.S., Urbich C., Mayer P., Wischhusenm J., Weller M., Kracht M., and Spyridopoulos I. Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. European Journal of Immunology 32 (2002) 2208-2217
15. Hobbie S., Chen L.M., Davis R.J., and Galan J.E. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. Journal of Immunology 159 (1997) 5550-5559
16. Inoue K., Slaton J.W., Kim S.J., Perrotte P., Eve B.Y., Bar-Eli M., Radinsky R., and Dinney C.P. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Research 60 (2000) 2290-2299
17. Jijon H.B., Panenka W.J., Madsen K.L., and Parsons H.G. MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. American Journal of Physiology. Cell Physiology 283 (2002) C31-C41
18. Kang D.G., Lee A.S., Mun Y.J., Woo W.H., Kim Y.C., Sohn E.J., Moon M.K., and Lee H.S. Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats. Biological & Pharmaceutical Bulletin 27 (2004) 366-370
19. Lee J.C., Lim K.T., and Jang Y.S. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochimica et Biophysica Acta 1570 (2002) 181-191
20. Lee J.I., and Burckart G.J. Nuclear factor kappa B: important transcription factor and therapeutic target. Journal of Clinical Pharmacology 38 (1998) 981-993
21. Lee S.H., Nan J.X., Zhao Y.Z., Woo S.W., Park E.J., Kang T.H., Seo G.S., Kim Y.C., and Sohn D.H. The chalcone butein from Rhus verniciflua shows antifibrogenic activity. Planta Medica 69 (2003) 990-994
22. Lee S.H., Seo G.S., and Sohn D.H. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by butein in RAW 264.7 cells. Biochemical and Biophysical Research Communications 323 (2004) 125-132
23. Lee S.H., Seo G.S., Park Y.N., and Sohn D.H. Nephroblastoma overexpressed gene (NOV) expression in rat hepatic stellate cells. Biochemical Pharmacology 68 (2004) 1391-1400
24. Lee S.H., Seo G.S., Park Y.N., Yoo T.M., and Sohn D.H. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochemical Pharmacology 68 (2004) 2367-2378
25. Luca M., Huang S., Gershenwald J.E., Singh R.K., Reich R., and Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. American Journal of Pathology 151 (1997) 1105-1113
26. Mahabeleshwar G.H., and Kundu G.C. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3-kinase activity in breast cancer cells. Journal of Biological Chemistry 278 (2003) 6209-6221
27. Malinin N.L., Boldin M.P., Kovalenko A.V., and Wallach D. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385 (1997) 540-544
28. Masuda H., Takahashi Y., Asai S., and Takayama T. Distinct gene expression of osteopontin in patients with ulcerative colitis. Journal of Surgical Research 111 (2003) 85-90
29. Masuda H., Takahashi Y., Asai S., Hemmi A., and Takayama T. Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn's disease and diverticulitis. Journal of Gastroenterology 40 (2005) 409-413
30. Medina C., and Radomski M.W. Role of matrix metalloproteinases in intestinal inflammation. Journal of Pharmacology and Experimental Therapeutics 318 (2006) 933-938
31. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., and Rao A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278 (1997) 860-866
32. Miyazaki Y., Tashiro T., Higuchi Y., Setoguchi M., Yamamoto S., Nagai H., Nasu M., and Vassalli P. Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene. Annals of the New York Academy of Sciences 760 (1995) 334-341
33. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Current Opinion in Cell Biology 16 (2004) 558-564
34. Naito Y., Takagi T., Kuroda M., Katada K., Ichikawa H., Kokura S., Yoshida N., Okanoue T., and Yoshikawa T. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Inflammation Research 53 (2004) 462-468
35. Philip S., Bulbule A., and Kundu G.C. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. Journal of Biological Chemistry 276 (2001) 44926-44935
36. Pikul S., McDow Dunham K.L., Almstead N.G., De B., Natchus M.G., Anastasio M.V., McPhail S.J., Snider C.E., Taiwo Y.O., Rydel T., Dunaway C.M., Gu F., and Mieling G.E. Discovery of potent, achiral matrix metalloproteinase inhibitors. Journal of Medicinal Chemistry 41 (1998) 3568-3571
37. Rangaswami H., Bulbule A., and Kundu G.C. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. Journal of Biological Chemistry 279 (2004) 38921-38935
38. Rice N.R., and Ernst M.K. In vivo control of NF-kB activation by IkBa. The EMBO Journal 12 (1993) 4685-4695
39. Roebuck K.A. Regulation of interleukin-8 gene expression. Journal of Interferon and Cytokine Research 19 (1999) 429-438
40. Salmela M.T., MacDonald T.T., Black D., Irvine B., Zhuma T., Saarialho-Kere U., and Pender S.L. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation. Gut 51 (2002) 540-547
41. Salmela M.T., Pender S.L., Karjalainen-Lindsberg M.L., Puolakkainen P., Macdonald T.T., and Saarialho-Kere U. Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scandinavian Journal of Gastroenterology 39 (2004) 1095-1104
42. Sato T., Nakai T., Tamura N., Okamoto S., Matsuoka K., Sakuraba A., Fukushima T., Uede T., and Hibi T. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 54 (2005) 1254-1262
43. Schuppan D., and Hahn E.G. MMPs in the gut: inflammation hits the matrix. Gut 47 (2000) 12-14
44. Sizemore N., Leung S., and Stark G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Molecular and Cellular Biology 19 (1999) 4798-4805
45. von Lampe B., Barthel B., Coupland S.E., Riecken E.O., and Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47 (2000) 63-73
46. Woo S.W., Lee S.H., Kang H.C., Park E.J., Zhao Y.Z., Kim Y.C., and Sohn D.H. Butein suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Journal of Pharmacy and Pharmacology 55 (2003) 347-352
47. Xu H.X., Wan M., Dong H., But P.P., and Foo L.Y. Inhibitory activity of flavonoids and tannins against HIV-1 protease. Biological & Pharmaceutical Bulletin 23 (2000) 1072-1076
48. Yang E.B., Guo Y.J., Zhang K., Chen Y.Z., and Mack P. Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives. Biochimica et Biophysica Acta 1550 (2001) 144-152